Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochem B Buil

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 12, 2025
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpointsMaiken Cavling Arendrup, Jesus Guinea, Sevtap Arikan-Akdagli, et al.
Emerging Microbes & Infections|February 3, 2022
Resistance profiling of <i>Aspergillus fumigatus</i> to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistanceJochem B Buil, Jason D Oliver, Derek Law, et al.
Microbiology Spectrum|May 25, 2023
Targeting the 16S rRNA Gene by Reverse Complement PCR Next-Generation Sequencing: Specific and Sensitive Detection and Identification of Microbes Directly in Clinical SamplesSimone J C F M Moorlag, Jordy P M Coolen, Bart van den Bosch, et al.
Journal of Fungi (Basel, Switzerland)|September 22, 2022
Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active ProphylaxisElizabeth A De Kort, Jochem B Buil, Steven Schalekamp, et al.
Mycoses|May 3, 2025
Performance Evaluation of Five Real-Time PCR Assays for the Detection of Candida auris DNAJochem B Buil, Bart van den Bosch, Suzan J van der Maas, et al.
The Journal of Hospital Infection|March 20, 2026
From Aspergillus fumigatus pathogen surveillance to Aspergillus disease surveillanceRebecca van Grootveld, Martha T van der Beek, Jochem B Buil, et al.
Open Forum Infectious Diseases|January 15, 2026
Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM StudySarah Sedik, Robina Aerts, Katrien Lagrou, et al.
Emerging Infectious Diseases|June 25, 2025
Emergence of Flucytosine-Resistant Candida tropicalis Clade, the NetherlandsFatima Zohra Delma, Bram Spruijtenburg, Jacques F Meis, et al.
Mycopathologia|October 8, 2025
No Evidence for Environmental Triazole Resistance Selection Route in Aspergillus Section Flavi, The Netherlands, 1994-2023Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, et al.
Mycoses|October 30, 2019
High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infectionsAlexander F A D Schauwvlieghe, Jochem B Buil, Paul E Verweij, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 12, 2025
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpointsMaiken Cavling Arendrup, Jesus Guinea, Sevtap Arikan-Akdagli, et al.
Emerging Microbes & Infections|February 3, 2022
Resistance profiling of <i>Aspergillus fumigatus</i> to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistanceJochem B Buil, Jason D Oliver, Derek Law, et al.
Microbiology Spectrum|May 25, 2023
Targeting the 16S rRNA Gene by Reverse Complement PCR Next-Generation Sequencing: Specific and Sensitive Detection and Identification of Microbes Directly in Clinical SamplesSimone J C F M Moorlag, Jordy P M Coolen, Bart van den Bosch, et al.
Journal of Fungi (Basel, Switzerland)|September 22, 2022
Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active ProphylaxisElizabeth A De Kort, Jochem B Buil, Steven Schalekamp, et al.
Mycoses|May 3, 2025
Performance Evaluation of Five Real-Time PCR Assays for the Detection of Candida auris DNAJochem B Buil, Bart van den Bosch, Suzan J van der Maas, et al.
The Journal of Hospital Infection|March 20, 2026
From Aspergillus fumigatus pathogen surveillance to Aspergillus disease surveillanceRebecca van Grootveld, Martha T van der Beek, Jochem B Buil, et al.
Open Forum Infectious Diseases|January 15, 2026
Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM StudySarah Sedik, Robina Aerts, Katrien Lagrou, et al.
Emerging Infectious Diseases|June 25, 2025
Emergence of Flucytosine-Resistant Candida tropicalis Clade, the NetherlandsFatima Zohra Delma, Bram Spruijtenburg, Jacques F Meis, et al.
Mycopathologia|October 8, 2025
No Evidence for Environmental Triazole Resistance Selection Route in Aspergillus Section Flavi, The Netherlands, 1994-2023Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, et al.
Mycoses|October 30, 2019
High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infectionsAlexander F A D Schauwvlieghe, Jochem B Buil, Paul E Verweij, et al.
Pageof 6